A Study of MHE in Patients With Liver Diseases

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Hepatic EncephalopathyMinimal Hepatic EncephalopathyOvert Hepatic Encephalopathy
Interventions
DIAGNOSTIC_TEST

neurophysiological tests, blood biomarkers.

Let the patients do neuropsychological tests and detect blood biomarkers.

Trial Locations (1)

Unknown

Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Qin Ning

OTHER

NCT04058327 - A Study of MHE in Patients With Liver Diseases | Biotech Hunter | Biotech Hunter